ArticleAnnals of translational medicine2019
Astym
Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrent healthcare providers function in an environment where there is increased emphasis on value-based models of reimbursement; therefore, the delivery of better patient outcomes is critical. Consequently, it is necessary to identify successful treatments that improve outcomes and can be applied across a broad range of clinic settings, treatment styles and therapist expertise.
methodsData from 2,450 patients who received Astym therapy as component of their outpatient rehabilitation (treatment group) was matched to data from 2,450 randomly chosen patients with similar orthopedic impairments who did not receive Astym therapy during their rehabilitation (control group). Data was collected across 116 clinics in 17 U.S. states. All patients completed a standardized functional status survey at admission and at discharge. The effectiveness (discharge functional status score), efficiency (number of treatment visits, treatment duration) and utilization (unit of functional improvement per visit) was compared across two groups. Ethics approval was not required for this study as this is an observational study, with both sets of participants receiving actual (not placebo) treatment.
resultsCompared to the control sample, patients who received Astym therapy as part of their rehabilitation had higher discharge functional status (FS) scores (68.5
conclusionsPatients with musculoskeletal disorders who received Astym therapy as part of the treatment process experienced increased treatment effectiveness as compared to those who did not receive Astym therapy. The addition of Astym therapy improved physical therapy outcomes for patients across a broad range of treatment styles, clinical settings and therapist expertise.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.